Masimo EBITDA Margin 2012-2026 | MASI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Masimo (MASI) over the last 10 years. The current EBITDA margin for Masimo as of March 31, 2026 is .
| Masimo EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-03-31 | $1.56B | $0.35B | 22.44% |
| 2025-12-31 | $1.53B | $0.35B | 22.97% |
| 2025-09-30 | $1.48B | $0.20B | 13.55% |
| 2025-06-30 | $1.45B | $0.16B | 10.80% |
| 2025-03-31 | $1.43B | $0.14B | 9.60% |
| 2024-12-31 | $1.40B | $0.11B | 8.17% |
| 2024-09-30 | $0.80B | $0.20B | 25.28% |
| 2024-06-30 | $0.94B | $0.20B | 21.73% |
| 2024-03-31 | $1.05B | $0.21B | 19.62% |
| 2023-12-31 | $1.28B | $0.21B | 16.24% |
| 2023-09-30 | $2.12B | $0.32B | 15.26% |
| 2023-06-30 | $2.19B | $0.31B | 13.95% |
| 2023-03-31 | $2.30B | $0.34B | 14.94% |
| 2022-12-31 | $2.04B | $0.35B | 17.05% |
| 2022-09-30 | $1.75B | $0.28B | 16.09% |
| 2022-06-30 | $1.50B | $0.33B | 21.68% |
| 2022-03-31 | $1.24B | $0.31B | 24.68% |
| 2021-12-31 | $1.24B | $0.31B | 25.18% |
| 2021-09-30 | $1.21B | $0.30B | 24.71% |
| 2021-06-30 | $1.18B | $0.29B | 24.47% |
| 2021-03-31 | $1.17B | $0.28B | 24.13% |
| 2020-12-31 | $1.14B | $0.28B | 24.83% |
| 2020-09-30 | $1.10B | $0.28B | 25.34% |
| 2020-06-30 | $1.05B | $0.27B | 25.67% |
| 2020-03-31 | $0.98B | $0.26B | 26.41% |
| 2019-12-31 | $0.94B | $0.24B | 25.99% |
| 2019-09-30 | $0.91B | $0.24B | 25.82% |
| 2019-06-30 | $0.90B | $0.23B | 25.89% |
| 2019-03-31 | $0.88B | $0.23B | 26.31% |
| 2018-12-31 | $0.86B | $0.23B | 26.66% |
| 2018-09-30 | $0.84B | $0.22B | 26.07% |
| 2018-06-30 | $0.83B | $0.21B | 25.91% |
| 2018-03-31 | $0.81B | $0.21B | 25.56% |
| 2017-12-31 | $0.79B | $0.20B | 25.82% |
| 2017-09-30 | $0.78B | $0.48B | 61.81% |
| 2017-06-30 | $0.76B | $0.48B | 62.93% |
| 2017-03-31 | $0.74B | $0.47B | 63.46% |
| 2016-12-31 | $0.71B | $0.45B | 63.53% |
| 2016-09-30 | $0.68B | $0.16B | 24.15% |
| 2016-06-30 | $0.66B | $0.16B | 23.34% |
| 2016-03-31 | $0.65B | $0.15B | 22.57% |
| 2015-12-31 | $0.63B | $0.14B | 21.55% |
| 2015-09-30 | $0.63B | $0.13B | 20.93% |
| 2015-06-30 | $0.62B | $0.13B | 20.26% |
| 2015-03-31 | $0.60B | $0.11B | 18.94% |
| 2014-12-31 | $0.59B | $0.12B | 19.76% |
| 2014-09-30 | $0.57B | $0.10B | 16.93% |
| 2014-06-30 | $0.55B | $0.09B | 16.97% |
| 2014-03-31 | $0.55B | $0.10B | 18.00% |
| 2013-12-31 | $0.55B | $0.09B | 16.85% |
| 2013-09-30 | $0.54B | $0.10B | 18.84% |
| 2013-06-30 | $0.52B | $0.10B | 18.51% |
| 2013-03-31 | $0.51B | $0.10B | 18.82% |
| 2012-12-31 | $0.49B | $0.09B | 19.07% |
| 2012-09-30 | $0.47B | $0.09B | 19.24% |
| 2012-06-30 | $0.46B | $0.09B | 20.09% |
| 2012-03-31 | $0.45B | $0.09B | 20.45% |
| 2011-12-31 | $0.44B | $0.09B | 21.41% |
| 2011-09-30 | $0.43B | $0.10B | 21.94% |
| 2011-06-30 | $0.43B | $0.10B | 22.79% |
| 2011-03-31 | $0.42B | $0.10B | 23.10% |
| 2010-12-31 | $0.41B | $0.11B | 27.59% |
| 2010-09-30 | $0.39B | $0.11B | 28.50% |
| 2010-06-30 | $0.38B | $0.11B | 29.02% |
| 2010-03-31 | $0.36B | $0.11B | 30.03% |
| 2009-12-31 | $0.35B | $0.09B | 25.50% |
| 2009-09-30 | $0.34B | $0.09B | 25.96% |
| 2009-06-30 | $0.33B | $0.09B | 26.67% |
| 2009-03-31 | $0.32B | $0.08B | 26.17% |
| 2008-12-31 | $0.31B | $0.08B | 25.08% |
| 2008-09-30 | $0.29B | $0.07B | 24.91% |
| 2008-06-30 | $0.28B | $0.07B | 24.73% |
| 2008-03-31 | $0.27B | $0.07B | 26.49% |
| 2007-12-31 | $0.26B | $0.07B | 28.52% |
| 2007-09-30 | $0.25B | $0.08B | 31.02% |
| 2007-06-30 | $0.24B | $0.08B | 33.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.578B | $1.527B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |